San Diego, CA -- (SBWire) -- 11/29/2021 --Certain directors of Avalo Therapeutics, Inc f.k.a. Cerecor Inc are under investigation over potential breaches of fiduciary duties.
Investors who purchased shares of Avalo Therapeutics, Inc. (NASDAQ: AVTX) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Avalo Therapeutics, Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders.
Rockville, MD based Avalo Therapeutics, Inc., a clinical-stage precision medicine company, discovers, develops, and commercializes therapeutics for patients with unmet clinical need in immunology, immuno-oncology, and rare genetic diseases.
Shares of Avalo Therapeutics, Inc. (NASDAQ: AVTX) declined from $5.71 per share in December 2019 to as low as $1.7 per share in March 2020.
Avalo Therapeutics, Inc. reported that its annual Total Revenue declined from $6.75 million in 2019 to $6.69 million in 2020, and that its Net Loss increased from $16.07 million in 2019 to $63.50 million in 2020.
On November 26, 2021, NASDAQ: AVTX shares closed on $2.04 per share.
Those who purchased shares of Avalo Therapeutics, Inc. (NASDAQ: AVTX) have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
NASDAQ: AVTX Investor Notice: Investigation over Potential Wrongdoing at Avalo Therapeutics, Inc f.k.a. Cerecor Inc
An investigation on behalf of investors in Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares over potential wrongdoing at Avalo Therapeutics, Inc. was announced.